EIF3E 抗体 (N-Term)
Quick Overview for EIF3E 抗体 (N-Term) (ABIN632164)
抗原
See all EIF3E 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- N-Term
-
特异性
- EIF3 E antibody was raised against the N terminal of EIF3
-
纯化方法
- Affinity purified
-
免疫原
- EIF3 E antibody was raised using the N terminal of EIF3 corresponding to a region with amino acids ELLQGKLDLLSDTNMVDFAMDVYKNLYSDDIPHALREKRTTVVAQLKQLQ
-
-
-
-
应用备注
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
说明
-
EIF3E Blocking Peptide, (ABIN937943), is also available for use as a blocking control in assays to test for specificity of this EIF3E antibody
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EIF0 antibody in PBS
-
浓度
- Lot specific
-
缓冲液
- PBS
-
注意事项
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
储存条件
- 4 °C/-20 °C
-
储存方法
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- EIF3E (Eukaryotic Translation Initiation Factor 3 Subunit E (EIF3E))
-
别名
- EIF3E
-
背景
- EIF3E belongs to the eIF-3 subunit E family.It is a component of the eukaryotic translation initiation factor 3 (eIF-3) complex, which is required for several steps in the initiation of protein synthesis. EIF3E is required for nonsense-mediated mRNA decay (NMD), It may act in conjunction with UPF2 to divert mRNAs from translation to the NMD pathway. The protein may interact with MCM7 and EPAS1 and regulate the proteasome-mediated degradation of these proteins.
-
分子量
- 52 kDa (MW of target protein)
-
途径
- Ribonucleoprotein Complex Subunit Organization, Hepatitis C
抗原
-